Nutriband Inc WT (NTRBW)

$1.20 -0.15 (-11.11%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	2.09M
Net Income (ttm)	-5.49M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	11,200
Avg Vol	1,938
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	32%
Beta	N/A
Analysts	Strong Sell
Price Target	N/A

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States